Organogenesis Holdings Community

Key Takeaways Delay in LCDs implementation offers a chance to capitalize on demand, boosting near-term revenue and market share for key products. Investments in clinical data and policy shifts could enhance reimbursement, access, and margins, driving sustained revenue growth and expansion in new markets.